Nsp12-IN-2
Nsp12-IN-2 (Compound 8), the triphosphate metabolite of 4'-thiouridine , is a SARS-CoV-2 Nsp12 inhibitor. Nsp12-IN-2 inhibits the RNA-dependent RNA polymerase (RdRp) activity of the SARS-CoV-2 Nsp12-Nsp7-Nsp8 complex, terminates RNA synthesis and also blocks the RNAylation and NMPylation of Nsp9. Nsp12-IN-2 is promising for research of infections caused by SARS-CoV-2, other coronaviruses, and other RNA viruses[1].
Product Specifications
CAS Number
667882-55-5
UNSPSC
12352005
Target
Drug Metabolite; SARS-CoV; Virus Protease
Related Pathways
Anti-infection; Metabolic Enzyme/Protease
Applications
COVID-19-anti-virus
Field of Research
Infection
Smiles
O=C(N([C@@H]1S[C@H](COP(OP(OP(O)(O[Na])=O)(O[Na])=O)(O[Na])=O)[C@@H](O)[C@H]1O)C=C2)NC2=O
Molecular Formula
C9H12N2Na3O14P3S
Molecular Weight
566.15
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Histone H1 (AE-4), CF594 conjugate, 0.1mg/mL
TAG-72 / CA72.4 (B72.3), CF568 conjugate, 0.1mg/mL
CD63 (MX-49.129.5), CF647 conjugate, 0.1mg/mL
